Evidence map›Paper›PMID 42583444›Full record

ReviewJournal of thoracic disease2026

Endoluminal approaches to postoperative air leaks.

Muhammad Arian, Yuri Terunuma, Shawn Nishi

Abstract readReview
In one paragraph

Review in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Muhammad ArianDepartment of Pulmonary, Critical Care and Sleep Medicine, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0002-7438-9552
Yuri TerunumaDepartment of Internal Medicine, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0003-0837-3744
Shawn NishiDepartment of Pulmonary, Critical Care and Sleep Medicine, University of Texas Medical Branch, Galveston, TX, USA.ORCID https://orcid.org/0000-0002-7510-2664

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Postoperative air leaks occur in up to 50% of patients following pulmonary resection, with 8-10% progressing to prolonged air leak (PAL) beyond postoperative day 5. PAL is associated with increased risk of empyema, reoperation, readmission, and prolonged hospitalization, imposing a substantial clinical and economic burden. This chapter provides a comprehensive review of the pathophysiology, risk stratification, diagnostic evaluation, and contemporary endoluminal treatment options for postoperative air leaks. Several preoperative prediction models-including the index of persistent air leak (IPAL), the prolonged air leak score (PALS), and the Gilbert score-have been developed to identify high-risk patients, though discriminatory performance remains moderate and no model-guided strategy has been shown to improve outcomes. Postoperative air leaks are classified temporally, physiologically as drainage-dependent PAL (DDPAL) or drainage-independent PAL (DIPAL), and by severity using analog or digital grading systems. Digital chest drainage systems offer objective airflow quantification and modestly reduce chest tube duration and hospital length of stay (LOS) compared with analog systems, though validated intervention thresholds are lacking. Accurate localization of the air leak source-distinguishing bronchopleural fistula (BPF) from alveolar-pleural fistula-is essential for guiding intervention. Sequential bronchoscopic balloon occlusion remains the most practical localization technique, while surgical methods including indocyanine green (ICG) fluorescence imaging offer complementary approaches. Endoluminal therapies encompass three mechanistic categories: one-way endobronchial valves (EBVs), bronchial occlusion devices (Watanabe spigots), and sealants [fibrin glue, cyanoacrylate, polyethylene glycol (PEG)-based hydrogel], supplemented by autologous blood patch (ABP) therapy. EBVs represent the most extensively studied modality, with a pooled success rate of 82% across 2,472 patients, though evidence is limited to observational studies. Emerging bioengineered approaches-including silk-elastin sponges, bio-three-dimensional (3D) printed cellular plugs, and lung-mimetic hydrofoam sealants-remain preclinical. With careful patient selection, physiologic classification, and appropriate device matching, endoluminal therapies offer minimally invasive alternatives that may reduce morbidity in patients with persistent postoperative air leaks who are not candidates for surgical re-exploration.

Indexed as

alveolar-pleural fistulabronchopleural fistula (BPF)bronchoscopyendobronchial valve (EBVs)Prolonged air leak (PAL)

Identifiers

PMID42583444
PMCPMC13460105

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.